Cost-effectiveness of single-use negative-pressure therapy compared with standard care for prevention of reconstruction failure in prepectoral breast reconstruction
Authors:
- J A MurphyJMJ A Murphy
- D MyersDMD Myers
- R SearleRSR Searle
Open Access
- 5 March 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 5 (2)
Abstract
Background: Single-use negative-pressure wound therapy (sNPWT) has been reported to reduce the incidence of reconstruction failure in prepectoral breast reconstruction compared with standard surgical dressings. The aim of this economic evaluation was to investigate the cost-effectiveness of sNPWT compared with standard care for the prevention of reconstruction failure in prepectoral breast reconstruction in the UK.Method: A decision tree model was used to estimate the expected cost and effectiveness per patient. Effectiveness was measured both by the number of reconstruction failures avoided and the gain in quality-adjusted life-years (QALYs). The baseline incidence of reconstruction failure (8.6 per cent) was taken from a recently published study of 2655 mastectomies in the UK. The effectiveness of sNPWT used results from a clinical study comparing sNPWT with standard dressings. Previously published utility weights were applied. The cost of reconstruction failure was estimated from detailed resource data from patients with reconstruction failure, applying National Health Service reference costs. One-way, probabilistic, scenario and threshold analyses were conducted.Results: The undiscounted cost per patient associated with reconstruction failure was estimated to be £23 628 (£22 431 discounted). The use of sNPWT was associated with an expected cost saving of £1706 per patient, an expected increase in QALYs of 0.0187 and an expected 0.0834 reconstruction failures avoided. Cost-effectiveness acceptability analysis demonstrated that, at a threshold of £20 000 per QALY, 99.94 per cent of the simulations showed sNPWT to be more cost-effective than standard care.Conclusion: Among patients undergoing immediate prepectoral breast reconstruction, the use of sNPWT is more cost-effective than standard dressings.Keywords
This publication has 20 references indexed in Scilit:
- Negative Pressure Wound Therapy Reduces Wound Breakdown and Implant Loss in Prepectoral Breast ReconstructionPlastic and Reconstructive Surgery - Global Open, 2020
- Reconstructive utilisation and outcomes following mastectomy surgery in women with breast cancer treated in EnglandThe Annals of The Royal College of Surgeons of England, 2020
- Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teamsBritish Journal of Surgery, 2019
- The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 studyBritish Journal of Cancer, 2019
- Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort studyThe Lancet Oncology, 2019
- A Prospective Comparison of Short-Term Outcomes of Subpectoral and Prepectoral Strattice-Based Immediate Breast ReconstructionPlastic and Reconstructive Surgery, 2018
- Prepectoral Implant-Based Breast ReconstructionPlastic and Reconstructive Surgery - Global Open, 2017
- Reducing infection risk in implant-based breast-reconstruction surgery: challenges and solutionsBreast Cancer: Targets and Therapy, 2016
- Cost-effectiveness of one-stage versus two-stage breast reconstruction in the United KingdomPlastic and Aesthetic Research, 2015
- A Meta-Analysis of Human Acellular Dermis and Submuscular Tissue Expander Breast ReconstructionPlastic and Reconstructive Surgery, 2012